Zymetech

January 2016

BUYER

Enzymatica AB is a Swedish-listed life science company that develops and sells medical products against common infectious diseases. The company had revenues of SEK 19 million in 2014.

TARGET

Zymetech ehf. is an Icelandic company active in research, development, production and sales of marine-derived enzymes for therapeutic application. The company had revenues of ISK 146 million in 2014.

SELLER

Zymetech was sold by the company’s main owners and founding family.

TRANSACTION

An exclusively negotiated transaction.